Cargando…
Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies
Autoimmune diseases of the peripheral nervous system have so far been treated mainly with exogenous high-dose intravenous immunoglobulins (IVIg), that act through several mechanisms, including neutralization of pathogenic autoantibodies, modulation of lymphocyte activity, interference with antigen p...
Autores principales: | Briani, Chiara, Visentin, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294114/ https://www.ncbi.nlm.nih.gov/pubmed/35349079 http://dx.doi.org/10.1007/s13311-022-01222-x |
Ejemplares similares
-
Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy
por: Khadilkar, Satish V., et al.
Publicado: (2011) -
A diagnostic score for anti‐myelin‐associated‐glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti‐myelin‐associated‐glycoprotein antibody
por: Doneddu, Pietro E., et al.
Publicado: (2022) -
Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients
por: Alkhawajah, Nuha M., et al.
Publicado: (2014) -
Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies
por: Briani, Chiara, et al.
Publicado: (2021) -
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance
por: Visentin, Andrea, et al.
Publicado: (2022)